Mirimus delivers scalable, high-precision solutions that accelerate drug discovery and bring new therapies closer to patients.
Explore Our ServicesAt Mirimus, innovation meets precision. As an XPRIZE award–winning biotech and preclinical CRO, we accelerate the development of tomorrow’s therapies with cutting-edge gene editing and RNAi technologies that power next-generation disease models and preclinical testing solutions.
Learn More
We drive advancements in human health by providing high-quality animal and cell models for critical in vivo studies. We empower researchers to gain precise control over in vivo gene expression by designing accurate, translatable, genetically engineered animal and cellular models with adjustable activity, covering all levels from complete knockout to overexpression and modification of endogenous loci.
Accelerate your path to clinical success with robust preclinical testing of small molecules, biologics, RNAi therapies, and CRISPR innovations.
Learn More.png)
Unlock the therapeutic potential of RNA Interference (RNAi) and accelerate the development of new therapies for the world’s most challenging diseases.
Learn More.png)
Recreate the architecture and physiology of organs with clinically relevant 3D tissue cultures developed from human induced pluripotent stem cells (iPSCs) or mouse tissues.
Learn More
Customize RNAi and genetically engineered mouse and rat models for drug discovery and target validation.
Learn More
.png)
.png)
